MDNews - Lower Hudson/Bronx

May 2017

Issue link: https://viewer.e-digitaledition.com/i/821079

Contents of this Issue

Navigation

Page 8 of 23

va rious causes, including at y pica l facia l pa in, ca ncer pa in, fa iled back sy ndrome, spina l cord injur y, spine surger y a nd trauma , a mong others. The use of neuromodu lation for t he treatment of pa in ha s ga ined increa sing popu la rit y for its sa fet y, eff icacy a nd minima l side effects. "Historica lly, when employing neurostimulation for the treatment of pa in, we relied on pa resthesias — that is, the patient needed to feel some sor t of tingling or buzzing from a neurostimulator device impla nted in the body — a nd the device a nd process were intended to ma sk the pa in," Dr. Snyder says. " However, in the past f ive yea rs, our f ield has seen the advent of exciting new devices a nd techniques — such as high-frequency (H F) SCS a nd dorsa l root ga ng lion (DRG) stimu la- tion — that don't require the patients to feel stimulation, a nd, fur thermore, have the potentia l to mask the pa in even better." A 2015 Neurosurgery study showed that 76.5 percent of patients with back pa in using the Senza system, a H F SCS system approved by t he FDA in May 2015, ex per ienced subst a nt ia l, la st i n g pa i n rel ief, com- pa red with 49.3 percent of those having low-frequency stimu lation. Moreover, about 73¦ percent of patients w it h leg pa i n repor ted sig n i f ica nt pa i n reduction, compa red to a lmost 49 percent of those undergoing low-frequency stimulation. DRG stimulation, a nother adva nced pa in treatment that recently became available, is an additiona l therapy Dr. Snyder employs for the treatment of chronic pa in. By electrica lly stimulating the DRG, which plays a n integ ra l role in the reg ulation of chronic neuropathic pain, via electrodes connected to the brain, Dr. Snyder is able to modulate neuropathic pain signa ls. DRG neuro- modulation can even be used for treating pain that hasn't responded well to traditiona l SCS, such as pa in in the hand, chest, abdomen, foot, knee and groin, according to the Internationa l Neuromodulation Societ y. However, DRG is a lso a n e f fe c t iv e m e a n s of i nt e r fe r i n g w it h pa i n a ssociated w it h spi ne surgery, hernia surgery and complex reg iona l pa in sy ndrome (CR PS), a mong ot hers, Dr. Snyder notes. For instance, a December 2016 Pain st udy showed t hat 81 percent of patients with complex regiona l pain syndrome or causa lgia in the lower extremities undergoing DRG stimu- lation enjoyed at least a 50-percent reduction in pa in, compa red to a n a lmost 56 percent of patients who had conventiona l SCS. "Between HF SCS a nd DRG, it 's a new frontier for neurostimu la- tion therapy for pa in," Dr. Snyder Meet Dr. Snyder BRIA N J. SN Y DER, MD, a fellowship-trained functional neurosurgeon at Neurological Surgery, P.C., specializes in the treatment of movement disorders, such as Parkinson's disease (PD), essential tremor, dystonia, epilepsy and seizure disorders, and intractable pain. He is an expert in deep brain stimulation (DBS), which uses microelectrode recording, vagus nerve stimulation, and procedures for mapping, recording, identifying and surgically resectioning seizure foci in the brain. In treating chronic pain, Dr. Snyder employs neu- romodulation, including spinal cord stimulation and peripheral nerve stimulation. He also has experience in revision surgery for neurostimulators that are broken, poorly placed or producing inadequate results. He utilizes intrathecal pumps for both spasticity and pain when appropriate. Dr. Snyder has expertise in a number of surgeries, including DBS and the innovative NeuroPace. He is certi- fied in both Gamma Knife and CyberKnife radiosurgeries. He earned his medical degree from Temple University School of Medicine and completed an internship in general surgery, in addition to a residency in neurologi- cal surgery, at Mount Sinai School of Medicine, where he became chief resident in neurological surgery. Following his residency, Dr. Snyder completed a fellowship in stereotactic and functional neurosurgery under Andres Lozano, MD, PhD, at Toronto Western Hospital, University of Toronto. Dr. Snyder has published and presented a number of papers in the field of functional neurosurgery, with emphases on surgery for primary dystonia, seizure out- comes associated with cavernous malformations, DBS for depression and PD, and Gamma Knife radiosurgical treatment of tremor. Dr. Snyder discusses upcoming surgical cases with his assistant, Michelle Barrios. 0 9 M D N E W S . C O M /// M D N E W S L O W E R H U D S O N / B R O N X ■ 2 017

Articles in this issue

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - May 2017